Philip Morris International Inc.

Company facts

Industry

Cigarettes

Headquarters

Stamford, Connecticut

Most recent report

8-K, filed Sep 8, 2026

Incorporated

Virginia

Filings on record

1,002+ filings

On EDGAR

CIK 1413329

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Jun 2026 10-Q

SECSift found 2 of 10 sections worth reading, with 3 positive, 3 notable, and 2 negative flags.

• Financial Statements (Item 1)

  Core results, RBH impairment, debt shift, and litigation updates require attention.
  Positive

  • Italian subsidiary acquitted in full in anti-corruption case on July 3, 2026.
  Notable

  • New segment structure effective Jan 1, 2026, with primary profitability measure changed to segment gross profit.
  • ZYN class action trial set for December 7, 2026; no loss accrued.

• Management's Discussion (Item 2)

  MD&A with specific results, impairment, Russia risk, and regulatory wins.
  Positive

  • Net revenues up 9.8% to $21.3B in H1 2026, driven by pricing in international combustibles.
  • FDA authorized modified risk claim for 20 ZYN nicotine pouch products in June 2026, a first in this category.
  Notable

  • German HTP tax appeal expected oral hearing by Q4 2026; EUR 721M paid but outcome could reverse it.
  Negative

  • Diluted EPS down 8.4% to $3.36 in H1 2026; a $511M impairment on RBH equity investment hurt by $0.33.
  • Russian operations hold $5.6B in total assets; forced localization of distributor adds risk of impairment.

What changed: Jun 2026 vs. Mar 2026

About 11% of PM's Jun 2026 10-Q is new information. 103 paragraphs were added, 276 changed, and 79 removed. Below are the most important lines SECSift identified.

• Item 2 214
• Item 1 114
• Item 6 3
• Item 1A 1
• Item 5 1